Arca
Skip to content
Tools
Tools

-tant

Drugs that block neurokinin (tachykinin) receptors.

  • Drugs ending in -tant: 29
  • Approved somewhere: 9
  • With a US drug page: 9

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-tant
Class
Drugs that block neurokinin (tachykinin) receptors
Most common targets
TACR1 (16), TACR3 (4), TACR2 (3), NTSR1 (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -tant or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
BeractantApproved—Surfactant agent
CalfactantApproved—Surfactant agent
Poractant alfaApproved—Surfactant agent
LucinactantPhase 3—Surfactant agent
Pumactant———
IbodutantPhase 3TACR2Neurokinin 2 receptor antagonist
SaredutantPhase 3TACR2Neurokinin 2 receptor antagonist
NepadutantPhase 2TACR2Neurokinin 2 receptor antagonist
ReminertantPhase 2NTSR1Neurotensin receptor 1 antagonist
FezolinetantApprovedTACR3Neurokinin 3 receptor antagonist
ElinzanetantPhase 3TACR1, TACR3Neurokinin 1 receptor antagonist
PavinetantPhase 2TACR3Neurokinin 3 receptor antagonist
TalnetantPhase 2TACR3Neurokinin 3 receptor antagonist
OsanetantEarly phase 1——
AprepitantApprovedTACR1Neurokinin 1 receptor antagonist
RolapitantApprovedTACR1Neurokinin 1 receptor antagonist
TradipitantPhase 3TACR1Neurokinin 1 receptor antagonist
FosaprepitantApprovedTACR1Neurokinin 1 receptor antagonist
FosnetupitantApprovedTACR1Neurokinin 1 receptor antagonist
NetupitantApprovedTACR1Neurokinin 1 receptor antagonist
CasopitantPhase 3TACR1Neurokinin 1 receptor antagonist
BurapitantPhase 2TACR1Neurokinin 1 receptor antagonist
OrvepitantPhase 2TACR1Neurokinin 1 receptor antagonist
SerlopitantPhase 2TACR1Neurokinin 1 receptor antagonist
VestipitantPhase 2TACR1Neurokinin 1 receptor antagonist
VofopitantPhase 2TACR1Neurokinin 1 receptor antagonist
Ezlopitant—TACR1Neurokinin 1 receptor antagonist
Figopitant—TACR1Neurokinin 1 receptor antagonist
Maropitant—TACR1Substance-P receptor antagonist

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.